15.3339  0.184 (1.22%)		04-26 15:21
Open: 15.17 High: 15.35 Volume: 3,919		Pre. Close: 15.1496 Low: 15.17 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	19.14	1-year :	20.08
Resists	First :	16.39	Second :	17.2
Pivot price	15.75
Supports	First :	15.09	Second :	12.55
MAs	MA(5) :	15.26	MA(20) :	16.01
	MA(100) :	16.45	MA(250) :	16.4
MACD	MACD :	-0.5	Signal :	-0.4
%K %D	K(14,3) :	13.2	D(3) :	11.6
RSI	RSI(14): 35.4
52-week	High :	18.52	Low :	13.37

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ WDNA ] has closed above bottom band by 32.5%. Bollinger Bands are 62.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	15.36 - 15.43	15.43 - 15.5
Low:	14.98 - 15.07	15.07 - 15.15
Close:	15.21 - 15.34	15.34 - 15.47

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Fri, 19 Apr 2024
9 Best Biotech ETFs for 2024 - AOL

Thu, 18 Apr 2024
WisdomTree BioRevolution Fund (BATS:WDNA) Trading Down 1.1% - Defense World

Thu, 29 Feb 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money

Thu, 23 Mar 2023
Oxford Nanopore scores higher revenues and smaller losses in 2022 - Opto RoW

Sat, 18 Dec 2021
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool

Mon, 21 Jun 2021
The BioRevolution: An ETF That Taps Into Nearly Everything - ETF Trends

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: ETF
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.